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Abstract
Climate change is the biggest challenge facing humanity today. The associated 
global warming and humidification, increases in the severity and frequency of 
extreme climate events, extension of the ranges of vector‐borne diseases, and the 
consequent social and economic stresses and disruption will have major negative 
consequences on many aspects of health care. People whose resilience to change is 
already impaired may suffer disproportionately from these environmental changes, 
which are of unprecedented reach and magnitude. There has been little connection 
made so far between climate change and epilepsy. We briefly review the history of 
climate change science and the subsequent response of the global scientific com-
munity. We consider how climate change effects might in general affect health and 
disease. We consider some of the underlying complex interactions that, for example, 
favor the spread of vector‐borne diseases and how climate models operate and may 
help plan for global and local changes. We then speculate specifically on how these 
generic ideas may apply specifically to epilepsy. We consider these impacts at levels 
from molecular to the epidemiological. Data are sparse, and there is undoubtedly a 
need for more information to enable better estimation of possible effects of climate 
change on care in epilepsy. We also consider how the professional activities of those 
involved in epilepsy health care might contribute to global carbon emissions, for 
example, through flying for conference attendance. Healthcare organizations across 
the world are already considering, and responding to, many of these issues. We argue 
for more research in this area, but also for action today. Actions today are likely to 
generate cobenefits for health care, including care in epilepsy, resulting from efforts 
to decarbonize, mitigate effects of climate change that has already happened, and 
plan for adaptation to climate change.
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1 |  INTRODUCTION
Climate change, dominated by climate warming, is accepted 
by the majority of informed authorities as a clear feature 
of the Anthropocene era, and is becoming the lived experi-
ence shared by many of us globally, as we comment with 
increasing frequency about the unseasonal weather and the 
environment transforming around us. The effects of climate 
change will be pervasive, with no sphere of human endeavor 
likely to be untouched. As the 5th assessment report from the 
Intergovernmental Panel on Climate Change (IPCC) states: 
“Continued emission of greenhouse gases will cause further 
warming and long‐lasting changes in all components of the 
climate system, increasing the likelihood of severe, pervasive 
and irreversible impacts for people and ecosystems. Limiting 
climate change would require substantial and sustained re-
ductions in greenhouse gas emissions which, together with 
adaptation, can limit climate change risks.”1
The risks to human health posed by climate change have 
already received extensive attention. The fourth edition, pub-
lished in 2018, of the Lancet Countdown on health and cli-
mate change stated climate change was “the biggest global 
health threat of the 21st century,” warning that failure to take 
action could lead to disasters that “disrupt core public health 
infrastructure and overwhelm health services.”2 A further 
Lancet commission report details the interaction between 
significant healthcare challenges (a “syndemic”), working as 
multipliers that exacerbate unitary global challenges, such as 
obesity, undernutrition, and climate change.3
Several authorities and organizations have launched pro-
grams around the effects of climate change. The Global Climate 
and Health Alliance, formed in 2011, “works to tackle climate 
change and to protect and promote public health” and provides 
useful links and resources (http://clima teand healt halli ance.
org/). Several international groups, nations, and regions have 
their own healthcare initiatives focused on climate change, such 
as the Medical Society Consortium on Climate and Health in 
the United States (https ://medso cieti esfor clima tehea lth.org/), 
the UK Health Alliance on Climate Change (http://www.
ukhea lthal liance.org/), Doctors for the Environment Australia 
(https ://www.dea.org.au/), the Regional Institute of Health 
Medicine and Research (Rajasthan, India) (http://www.rihmr.
org/), the European Environment and Health Youth Coalition 
(http://www.eehyc.org/), and the UK NHS (https ://www.sduhe 
alth.org.uk/policy-strat egy/repor ting/nhs-carbon-footp rint.
aspx), carbon emissions from which are estimated to account 
for between 4% and 6% of the total UK carbon footprint. The 
World Health Organization has made clear the health bene-
fits of mitigating climate change far outweigh the costs.4 The 
US healthcare provider Kaiser Permanente announced in 2018 
that it would become carbon neutral by 2020.5
Funders are increasingly supporting research into the 
health effects of climate change, typically with a focus on 
mitigation strategies. It seems unlikely that any human 
disease area will escape the pervasive anticipated and un-
foreseen consequences of climate change. Noting that the ep-
ilepsies are strongly influenced by environmental factors, we 
wished to start to consider how climate change might affect 
the epilepsies, to raise awareness within the epilepsy com-
munity of these issues, and to facilitate and promote efforts 
by people affected by epilepsy, families and carers, and ep-
ilepsy professionals, to begin to address what action we can 
take. Individuals may already be taking steps in their own 
private lives, for example, by working out their own carbon 
footprint (https ://footp rint.wwf.org.uk/#/ ‐ a very easy to use 
and enlightening tool) and taking effective actions.6 Patients, 
clinicians, and scientists across the world, as a community, 
may have ideas and initiatives for shared observations and 
mitigation measures to reduce the potential added burden of 
climate change for those with epilepsy. We here consider the 
history of climate change, review the current state of science 
and global efforts to tackle climate change, describe how cli-
mate change can affect human health and disease, and then 
address the particular impacts there may be on the epilepsies, 
how health care in the epilepsies might contribute to climate 
change, what can be done to mitigate the effects, and how 
progress might be achieved.
2 |  CLIMATE CHANGE: A BRIEF 
SURVEY OF THE HISTORY AND 
CURRENT STATUS
Climate change science has a much longer history than 
most people realize, dating back to the 19th century when 
Joseph Fourier recognized that the Earth's atmosphere kept 
the planet warmer than would be the case in a vacuum. He 
Key Points
• Climate change is already affecting many aspects 
of daily life and health care, and has the potential 
to overwhelm healthcare systems.
• Warming and humidity changes will strongly af-
fect human disease risks, such as ranges of vec-
tor‐borne infections, stress, and biodiversity loss.
• Many of the accompanying environmental, infra-
structural, and socioeconomic changes will ad-
versely impact the epilepsies at several levels.
• For the sake of people with epilepsy, professionals 
should consider their own professional contribu-
tions to climate change.
• More research is needed; professionals can al-
ready take action.
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effectively discovered the greenhouse effect: the passage of 
visible light waves through the atmosphere to the earth's sur-
face, their absorption, and re‐emission as infrared radiation, 
which can then be absorbed by certain types of gases in the 
atmosphere, increasing surface temperatures. Eunice Newton 
Foote was the first to suggest that the warming effect of the 
sun would be increased in the presence of carbon dioxide 
(CO2: then called “carbonic acid”). Her work was presented 
by Professor Joseph Henry at the American Association for 
the Advancement of Science meeting in August 1856. John 
Tyndall then examined the absorption of infrared radiation 
in different gases, discovering the greenhouse gases (GHG) 
CO2, methane, and water vapor in 1859. Swedish scientist 
Svante Arrhenius was the first to link human activity to 
global warming. In 1896, he published “On the Influence 
of Carbonic Acid in the Air upon the Temperature of the 
Earth,” calculating that a doubling of atmospheric CO2 (now 
called the “climate sensitivity”) would give a total warming 
of 5‐6°C. In later work, he revised this downward to 4°C.7 
This is not dissimilar to the range reported by the IPCC’s 
5th Assessment Report from the latest generation of global 
climate models.
Events then jump almost 100 years to the modern era when 
the first conference on climate change, a joint United Nations 
Environment Programme (UNEP)/World Meteorological 
Organization (WMO)/International Council for Science 
(ICSU) Conference on the "Assessment of the Role of Carbon 
Dioxide and Other Greenhouse Gases in Climate Variations 
and Associated Impacts," in 1985 concluded that GHG "are 
expected" to cause significant warming in the next cen-
tury. This led to the establishment of the Intergovernmental 
Panel on Climate Change (IPCC) in 1988, whose role is to 
“assess the scientific, technical and socio‐economic infor-
mation relevant for the understanding of the risk of human‐
induced climate change,” and the United Nations Framework 
Convention on Climate Change (UNFCCC), an international 
environmental treaty adopted on May 9, 1992. The IPCC has 
issued a series of Assessment Reports once every 5‐6 years—
published in 1990 (First Assessment Report: FAR), 1995 
(Second Assessment Report: SAR), 2001 (Third Assessment 
Report: TAR), 2007 (Fourth Assessment Report: AR4), and 
2013/2014 (Fifth Assessment Report: AR5)—and supple-
mental and special topic reports that describe the state of 
scientific understanding at the time each report is prepared. 
Although there have now been five Assessment Reports (and 
the 6th is under construction), the range of potential warming 
with a doubling of atmospheric CO2 has not changed sub-
stantially from the estimate made with quite simple climate 
models in the FAR, or indeed by Arrhenius in 1896, with 
both the FAR and AR5 suggesting a range from 1.5 to 4.5°C.
Alongside this, the UNFCCC objective is to "stabilize 
greenhouse gas concentrations in the atmosphere at a level 
that would prevent dangerous anthropogenic interference 
with the climate system." The framework sets nonbinding 
limits on GHG emissions for individual countries, with no en-
forcement mechanisms. An annual Conference of the Parties 
(COP) assesses progress in dealing with climate change, 
and these have occurred since 1995, with many producing 
specific international treaties (“agreements” or “protocols”) 
around GHG emissions. This history includes (a) the Kyoto 
protocol—a legally binding agreement that industrialized 
countries will reduce their emissions of GHGs, adopted in 
1997 in Kyoto, Japan; (b) the Copenhagen Accord (2009), 
which recognized climate change as one of the greatest chal-
lenges of the present day and suggested actions should be 
taken to keep temperature increases to below 2°C; however, 
the document was not legally binding and does not contain 
any binding commitments for reducing CO2 emissions; (c) 
the Durban Platform (2011), which included a decision to 
adopt a legally binding treaty on climate change; the treaty 
terms were to be set out by 2015 and become effective in 
2020 and for the first time, it included developing countries 
and the United States; and (d) the Paris Agreement (2015) 
was a climate change accord agreed by ~200 countries in 
December 2015 that came into force on November 4, 2016, 
committing world leaders to keeping global warming below 
2°C and pursuing a tougher target of 1.5°C. Carbon emis-
sion curbs are not legally binding, but the framework of the 
accord, including a mechanism for periodically increasing 
pledges, is binding.
Since the FAR, the understanding of human influence 
on warming has improved through better earth observa-
tions and earth system modeling, with the AR5 stating that: 
(a) “Warming of the climate system is unequivocal, and 
since the 1950s, many of the observed changes are unprec-
edented over decades to millennia"8; (b) "Atmospheric con-
centrations of carbon dioxide, methane, and nitrous oxide 
have increased to levels unprecedented in at least the last 
800 000 years"8; and (c) “Human influence on the climate 
system is clear…It is extremely likely (95%‐100% probabil-
ity) that human influence was the dominant cause of global 
warming between 1951‐2010.”8 Special reports such as the 
recent SR159 (global warming of 1.5°C) examined the dif-
ference in impacts between 1.5 and 2°C warming, suggest-
ing that limiting warming to 1.5°C “is possible within the 
laws of chemistry and physics but doing so would require 
unprecedented changes” with “‘rapid and far‐reaching’ 
transitions in land, energy, industry, buildings, transport, 
and cities.” A 1.5°C limit would require global net anthro-
pogenic CO2 emissions to decline by about 45% from 2010 
levels by 2030, reaching net zero around 2050. To limiting 
global warming to below 2°C, CO2 emissions will need to 
decline by about 20% by 2030 and reach net zero around 
2075.
We are already living in a 1°C warmer world. The 
SR159 states “we are already seeing the consequences of 
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1°C of global warming through more extreme weather, ris-
ing sea levels and diminishing Arctic sea ice, among other 
changes … By 2100, global sea level rise would be 10 cm 
lower with global warming of 1.5°C compared with 2°C,”; 
and moreover, “Global warming is likely to reach 1.5°C be-
tween 2030 and 2052 if it continues to increase at the cur-
rent rate (high confidence).” If we continue on our current 
emission trajectory, then we are likely to reach 2.6‐4.8°C 
warming by 2100, with recent modeling results suggesting 
that the higher climate sensitivities could be more likely. 
In terms of personal emission targets, average personal 
emissions in 2010 were around 5 tons per person and to 
reach the 2°C target would require reduction to around 1.5 
tons by 2050.10 This is very ambitious and of is of course 
based on an equal sharing of emissions across the global 
population. In reality, the rich, Westernized nations use 
much more carbon per person than the poorer nations.10 
There is the potential for major reduction in personal car-
bon footprints in the Western world typically by reducing 
the major contributors of car travel, heating, electricity use, 
and flying.
3 |  CLIMATE CHANGE: HEALTH 
AND DISEASE
Existing variability in weather influences human health. For 
example, during clear summer days there is an increased 
occurrence of sunburn and Lyme disease, while during the 
winter, there is increased influence of influenza and falls. As 
climate change will influence weather, particularly weather 
extremes, then impacts on human health are likely. Hence, 
there has been an interest in the likely influence of climate 
change on human health for over 30 years, with a significant 
body of work now available on the health impacts of climate 
change.11‒15 Climate change may lead to multiple health 
impacts acting through a variety of different pathways, as 
shown conceptually in Figure 1.
Climate change will affect mean weather, such as rainfall 
amounts and temperature. In addition to changing average 
conditions, it may also increase variability and extremes 
(eg, more intense rainfall events). The latter is probably 
of most consequence for human health. Although globally, 
interannual temperature has not increased in variability,16 
there is evidence of regional changes in extremes,17,18 as 
both the mean climate and climate variability shift in re-
sponse to anthropogenic forcings (Figure 2). These shifts 
in weather will be moderated by local environmental con-
ditions and human adaptation, leading to changes in three 
broad categories of exposure that have the potential to in-
fluence health. The first are direct effects such as the in-
fluence of a heatwave upon mortality.19 The second are 
indirect exposures such as changing weather altering the 
growing season and distribution of plants, affecting pol-
len production, which in turn impacts on allergic disease20; 
other examples include changing weather patterns affecting 
mosquito breeding and life cycles, leading to changes in 
malaria and dengue fever (see below).21 Changes in tem-
perature and humidity alter the geography of vector‐borne 
diseases, by shifting vector breeding sites22 and altering the 
transmission windows of vector‐borne diseases.23 In many 
cases, more data are needed to characterize the relationships 
F I G U R E  1  Pathways through which climate change may influence health.1
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between vector, pathogen, and climate.24,25 Third, climate 
change may act through economic and social disruption, 
for example, leading to mental health effects from extreme 
events such as flooding26 or influencing global crop yields 
leading to increased hunger.27 Flooding, whether coastal, 
fluvial, or pluvial, carries direct risks of drowning28 as well 
as a range of health risks in the aftermath of the event, 
including the spread of water‐borne diseases,29 and the 
spread of microbial contaminants in buildings.30 The risk 
of exacerbating existing medical conditions, through dis-
rupted access to medicines and medical facilities, is also 
a concern.
However, changing exposure to extreme weather does 
not automatically lead to health impacts, and the gray box 
in Figure 1 highlights the important moderating influence 
that health care and wider public health capability can have 
in ameliorating potential impacts. Put simply, appropriate 
health care and public health input can reduce health im-
pacts. It is important to recognize that these capabilities are 
dynamic over time. Furthermore, they can respond (ie, adapt) 
to new situations. One prominent example of such an adap-
tation occurred in response to the 2003 European heatwave 
during which over 70 000 additional deaths were recorded.19 
City dwellers are at particular risk of heat stress given the 
urban heat island effect.31 Modeling suggests that in summer 
2003, when an estimated 735 people died of causes relat-
ing to extreme heat in central Paris, anthropogenic climate 
change increased the risk of heat‐related mortality by approx-
imately 70%,32 illustrating the scale of the issue. In response, 
many European countries developed early warning systems 
for heatwaves and national advice and guidelines on adap-
tation to reduce potential health impacts.33 Adapting public 
health capabilities will play an important role in responding 
to climate change.
The arrows in Figure 1 indicate feedback mechanisms be-
tween societal infrastructure, public health, and adaptation 
measures and climate change. Measures to reduce health im-
pacts may also reduce GHG emissions. Examples include the 
health and environmental cobenefits of low carbon diets.34,35
4 |  CLIMATE MODELS: 
PROVIDING PROJECTIONS FOR 
PLANNING
Much of our understanding of likely impacts from cli-
mate change in the coming decades comes from climate 
models. Atmosphere‐Ocean General Circulation Models 
(AOGCMs)36 use the laws of physics to compute atmos-
pheric, oceanic, and other environmental variables, and 
represent different processes and interactions in the climate 
system, at a series of evenly spaced “cells” or unit areas 
around the globe. Although important tools in our under-
standing, they are complex and require considerable com-
putational resource to run. For this reason, the cells used by 
state‐of‐the‐art global climate models typically span a large 
area in order to reduce the number of calculations required: 
in turn, the outputs generated are coarse. While these out-
puts are useful for identifying global and regional trends, 
we need to adapt them for local use (eg, to assess the likely 
impacts of climate change in a particular coastal city or 
tropical community). This is accomplished using “down-
scaling” methods,37,38 which involve using either statisti-
cal approaches or a higher resolution model over a limited 
area to add greater detail.39,40 Unlike short‐term weather 
forecasts, which are dependent on the initial state of the 
atmosphere, longer‐term projections from climate models 
are largely dependent on trajectories of global development 
and on how fluctuating concentrations of GHGs impact the 
F I G U R E  2  Schematic showing the effect on extreme 
temperatures when (A) the mean temperature increases, (B) the 
variance increases, and (C) when both the mean and variance increase 
for a normal distribution of temperature1
6 |   SISODIYA et Al.
balance of sunlight absorbed by the Earth and energy radi-
ated back into space. Thus, these longer‐term projections 
are subject to substantial uncertainty not related to the cli-
mate system. In the most recent model simulations, these 
trajectories are characterized by the representative con-
centration pathways (RCPs),41 a comprehensive dataset of 
changes to the Earth's energy balance under different pos-
sible futures. However, even when models are run with the 
same RCP, intermodel variability arises due to differences 
in how models represent processes, leading to different pro-
jected future climate states. For this reason, a multimodel 
ensemble is often used, in which uncertainty is considered 
to be represented by the spread of model projections.
The various choices and inferences made at each stage of 
the modeling process can therefore yield a substantial enve-
lope of uncertainty in local impacts. Yet, despite these un-
certainties, consistent findings with relevance for epilepsy 
emerge. For instance, models agree exceptionally well on 
estimates of heat stress metrics, which combine temperature 
and humidity.42 Furthermore, each generation of models rep-
resents an advance in our understanding of climate processes 
and a refinement of modeled processes. For example, for a 
number of extreme temperature indices, the spread among 
the most recent Coupled Model Intercomparison Project 
Phase 5 models (CMIP5; CMIP is a collaborative framework 
for supporting assessments of climate change and fostering 
model development, in which international modeling groups 
perform simulations based on preagreed scientific objectives, 
generating a database of model outputs with common stan-
dards) is less than the spread among the previous generation 
CMIP3 models, even though the project now contains more 
models.43
The burden of many of these changes will be felt by those 
least equipped to adapt. Models project increases in tempera-
ture variability in Amazonia, Southern Africa, the Sahel, 
India, and South‐East Asia over the coming decades.44 In 
India, models also indicate an intensification of heatwaves, 
with areas that do not currently experience heatwaves becom-
ing severely affected this century.45 Thus, models can help 
us understand where we can expect the effects of climate 
change to be most marked and what those effects might be, 
in turn helping us plan for the likely challenges that will need 
to be addressed for health care in general, and epilepsy in 
particular.
5 |  IMPACTS OF CLIMATE 
CHANGE ON EPILEPSY
As the climate changes, we can expect there to be particu-
lar implications for epilepsy. These impacts might manifest 
at the level of altered risk of epilepsy per se, altered risk of 
seizures in established epilepsy, consequences for epilepsy 
treatments, and outcomes, with effects more likely to affect 
those not favored in the first place by geography and eco-
nomics. We can expect inequalities in epilepsy health care to 
be further exacerbated.
Climate warming leads to spread of vectors for infections, 
which is already being reported, and more can be anticipated. 
Climate‐driven hyperthermia, fevers, food and water stress, 
and starvation may further compound other difficulties as 
well as being directly relevant themselves. Moreover, while 
humans are remarkably adaptable and have found niches in 
almost every terrestrial environment, climate change will su-
perimpose unprecedented rates and types of change.
A number of vector‐borne infections can cause epilepsy 
or seizures in the acute phase. Chikungunya virus infection is 
associated with seizures as part of a multisystem acute illness 
in 10% of patients,46 while there are case reports of epilepsy 
as part of the chronic sequelae of neonatal chikungunya en-
cephalitis.47 Epilepsia partialis continua has been reported 
with dengue encephalitis.48 Vertical Zika virus infection can 
lead to epilepsy even in the absence of microcephaly,49 and 
the epilepsy is typically drug‐resistant.50 If climate change 
leads to a spread of the vector carrying the infectious agent, 
then there will be an accompanying risk of spread of infec-
tion‐related epilepsy or acute seizures. Predictions are dif-
ficult, because the impact of climate change on vectors is 
multifactorial, and may be further compounded by multiplier 
effects as well as actions taking to mitigate its effects. It is 
already the case that the climate‐sensitive diseases affect the 
poorest populations the most, with higher prevalence and 
greater mortality, for several reasons.51 Outbreaks of vector‐
borne infections can easily overwhelm healthcare systems, 
for example, as shown by recent outbreaks of Ebola and Zika 
viruses, and emergence of infections in naïve populations 
or those that have lost immunity can be even more danger-
ous. Many factors related to climate change can alter vector 
ranges, survival, biting behavior, pathogen infection capacity, 
and thus ultimately the risk of disease in humans. Changes 
in rainfall patterns, drought‐rain cycles, and flood magnitude 
and frequency can all have effects, while human strategies to 
combat climate change, such as reestablishment of wetlands 
and green spaces, can, perversely, promote vector spread. 
Accounting for these effects in model simulations is particu-
larly challenging, but preliminary studies suggest, for exam-
ple, that climate change will favor the spread of dengue fever 
and other arthropod‐borne infections given the temperature 
sensitivity of many factors favoring the spread of infection.52 
Environmental, especially urban, effects of climate change 
might lead to the spread of cysticercosis,53 neurological in-
volvement from which is a major cause of epilepsy globally. 
A study focusing on the risk of spread of vector‐borne disease 
in the UK resulting from climate change suggests that a 1°C 
rise in temperature would permit Chikungunya virus trans-
mission for 1‐3 months of the year across most of southeast 
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England by 2071‐2100, with changes in transmission ranges 
also found for a range of other arthropods.52
Malaria is caused by five species of Plasmodium trans-
mitted by Anopheles mosquitoes. In malaria‐endemic areas, 
up to 90% of the population may have parasites detectable in 
their blood. Plasmodium falciparum and Plasmodium vivax 
are associated with seizures and epilepsy,54 particularly sei-
zures during acute infections, and development of epilepsy 
has been documented following severe falciparum malaria. 
In addition, there is evidence that asymptomatic malaria par-
asitemia can precipitate seizures in those with epilepsy.55 
There are many models of the effect of climate change on the 
transmission of malaria, with the most significant and con-
sistent effects predicted to occur in the highlands in Africa 
and parts of South America and South‐East Asia.56 In other 
regions, the effect of climate change on malaria transmission 
may be minimal due to improved control measures and so-
cioeconomic factors, although the present decline in malaria 
transmission across the world depends on continued support 
for the current control measures. However, significant uncer-
tainties exist in these models, particularly in the areas that 
experience malaria epidemics. Furthermore, most of these 
models examined the effect of climate change on mosquitoes 
that carry P falciparum, but it is the Anopheles species that 
transmit P vivax (particularly Anopheles atroparvus) that are 
most likely to increase seizures and epilepsy in Europe.57 For 
example, in one model, a medium‐high scenario of climate 
change predicts that the southern half of Great Britain will 
be climatically suitable for P vivax malaria transmission by 
2030 and by 2080 even southern Scotland will be climatically 
suitable for 2 months of the year.58
Phenomena other than infections are also worsening with 
climate change. As conflicts arise, we can expect more head 
injuries as another cause of epilepsy. A study from a highly 
polluted city in China suggests that transient increases in air 
pollutants such as nitrogen dioxide and sulfur dioxide are as-
sociated with increased hospital visits for epilepsy, support-
ing findings from another study from Chile that reported an 
increased risk of hospitalization for epilepsy with increases 
in air pollutants.59 Another study identified a tentative link 
between higher relative air humidity and an increased risk 
of admission for an epileptic seizure (though higher ambient 
temperature was associated with a lower risk).60 These are 
preliminary studies that suggest the relationships, if correct, 
are complex with a need for more data. But, there is certainly 
a prevailing view that the outlook strongly favors strategies 
to forestall climate change rather than trying to deal with the 
consequences on epilepsy and seizures of the complicated 
environmental changes that will occur due to climate change.
Temperature can affect genes and proteins. Most genetic 
epilepsies are due to dysfunctional channels. As in much of 
epilepsy genetics, SCN1A is among the best studied in this 
regard. Some mutations in SCN1A that can cause epilepsy 
lead to defective folding of the encoded channel: Mutant 
channel insertion into a cell surface is temperature‐sensitive, 
for example, with increased insertion and current density at 
30°C compared to 37°C.61 Mutations in SCN1A can cause 
the rare, severe developmental and epileptic encephalopathy 
Dravet syndrome. While the effect of such dynamic changes 
in the context of prolonged periods of higher ambient tem-
perature in thermoregulating humans is difficult to predict, 
empirical and modeling data show direct effects of higher 
temperatures on sodium channel biophysical properties and 
neuronal dynamics.62 Elevated ambient temperatures due to 
hot baths increase seizure frequency in Dravet syndrome.63 
Anecdotally, the UK Dravet syndrome patient support group 
reported that during the sustained atypical high ambient 
temperatures of the summer of 2018, affected children expe-
rienced more seizures and greater lethargy, in keeping with 
survey data from the Netherlands.64 We previously reported 
the death of a young patient with Dravet syndrome who had 
been seizure‐free, but had been walking outside on the hot-
test day in Melbourne (Australia) for years, with a peak of 
46.5°C.65 There are other temperature‐sensitive epilepsies, 
though generally less well studied. An epilepsy‐related mu-
tation in SCN8A was associated with temperature‐sensitive 
protein expression and function.66 Other genetic epilepsies 
with fever‐induced seizures include those due to certain mu-
tations in the genes GABRG2, CHD2, STX1B: Temperature 
elevation can affect brain thermal regulation and epilepti-
form discharges and induce seizures in models carrying 
certain mutations in GABRG267 or STX1B.68 Moreover, 
seizures in many epilepsies, of all types, are more frequent 
with psychological stress. Climate change is projected to in-
crease population stress levels as it will affect mean climate, 
such as rainfall amounts and temperature, but also weather 
variability and extremes, probably of most consequence for 
human health.
There has been little research into the effects of climate 
change on treatments for epilepsy. Lorazepam, used in many 
parts of the world as an emergency treatment for seizures, is 
especially prone to degradation with higher mean kinetic tem-
perature.69 There are few data on other antiepileptic drugs 
(AEDs), and the summary of product characteristics for sev-
eral commonly used AEDs do not include specific temperature 
recommendations, while, for example, phenobarbital tablets 
should be stored below 25°C.70 Medication supply chains can 
be compromised even today: It is easy to see how disruption 
to infrastructure could threaten AED (and indeed any drug) 
supply, as indeed happened after an exemplar (but not climate 
change‐related) disruption in a highly organized, well‐devel-
oped economy in the Great East Japan earthquake of 2011.71 In 
addition, biodiversity loss is a feature of climate change: This 
may compromise sources, such as plant, microbial, and fungal 
species, from which the next antiepileptic drugs might emerge 
(see Figure 3).
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Moreover, poverty is associated with reduced access to 
health care, with the majority of people in the world today 
with epilepsy having no access to any AEDs. Most climate 
change projections anticipate that poverty is likely to in-
crease, with disproportionate effects for those already most 
vulnerable. Thus, we can anticipate that the negative influ-
ence of epilepsy on socioeconomic status and all‐cause risk 
of premature mortality will grow with climate change inde-
pendent of any direct effect on epilepsy biology.
6 |  CAN EPILEPSY CONTRIBUTE 
TO CLIMATE CHANGE?
As clinicians working in epilepsy, we seek to offer holistic 
care. For example, we consider comorbidities because their 
successful treatment is not only likely to be important per se, 
but also because the control of comorbidities may improve 
seizure control.72 We should, therefore, examine also whether 
there are facets of epilepsy care that might themselves con-
tribute to climate change and thus, following the discussion 
above, to worsening quality of life for people with epilepsy.
At an individual level as professionals, clinicians contrib-
ute to climate change mainly through their travel choices and 
needs, especially flights; other sources of importance include 
energy consumption (such as leaving devices on standby; of-
fice temperature settings, and the purchase of goods). In the 
UK, richer people are responsible for more carbon emissions 
than poorer people: the 10% most wealthy (likely to include, 
eg, most doctors) generated 10.3 tons of carbon emissions, 
while the 10% least wealthy (likely to include an overrepre-
sentation of people with epilepsy) generated 3.25 tons.73 Air 
travel overall may account for a small fraction of human car-
bon emissions, but is growing rapidly, and its environmental 
damage is difficult to engineer away. As an example, in Table 
1, we list the additional carbon emissions generated in 2018 
due to professional travel by three senior epilepsy clinicians.
7 |  WHAT CAN THOSE INVOLVED 
IN EPILEPSY DO?
Measures to address climate change may include attempts to 
reduce carbon emissions, and actions for mitigation and ad-
aptation.1 For epilepsy professionals, there may be steps that 
FIGURE 3 Example of a zebrafish behavioral assay showing 
anticonvulsant activity of a plant extract typically used for 
ethnomedicinal purposes to treat seizures in Cameroon. Zebrafish 
larvae were pretreated with the ethanolic plant extract (25 µg/mL) 
for 18 h before acute exposure to pentylenetetrazol (20 mmol/L). 
Pentylenetetrazol‐induced convulsive‐like behavior was measured 5 min 
after, using an automated video‐tracking device. Graph shows total 
distance traveled by larvae in millimeters per 5‐min interval during a 30‐
min tracking session. Data were analyzed using specialized software to 
quantify total larval movements and subjected to two‐way with repeated‐
measures ANOVA, followed by Bonferroni's post hoc test (n = 10‐12/
group). ***P<.001, *P<.05 (vs Veh + veh), ###P<.001, #P<.05 (vs 
Veh + PTZ). EXT, extract; PTZ, pentylenetetrazol; Veh, vehicle. Note: 
Total distance traveled by PTZ‐treated larvae is lower at later time 
intervals as larvae reach the equivalent of status epilepticus at this stage 
and are less able to move due to loss of posture—therefore accounting 
for lack of statistical significance between extract‐treated larvae
  Tons of carbon dioxide
SMS, neurologist in the UK 2.4 (additional emissions due to work flights)
UK average (per capita) 5.9 (per annum)
DHL, neurologist in the United States 3.7 (additional emissions due to work flights)
US average (per capita) 17.0 (per annum)
IES, neurologist in Australia 16.4 (additional emissions due to work 
flights)
Australia average (per capita) 17.0 (per annum)
Average figures
World average (per capita) 4.8 (per annum)
Africa (per capita) 1.1 (per annum)
Europe (per capita) 7.6 (per annum)
Note: DHL, Daniel H Lowenstein; IES, Ingrid E Scheffer; SMS, Sanjay M Sisodiya
T A B L E  1  Carbon emissions for work 
air travel in 2018 and comparison with per 
capita emissions across the world (world 
data from 2016)
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be included in daily practice. Raising awareness of climate 
change, its impact for people with epilepsy and our contribu-
tions to climate change is a start—the very purpose of this 
article. Concurrently, more research is required to investigate 
into climate change and epilepsy, to better define the risks 
and develop adaptations and mitigations.
Reduction of carbon emissions (“decarbonizing”) could 
begin with understanding the sources of carbon emissions at 
the individual level and monitoring of individual carbon con-
tributions, for both professionals and people with epilepsy. 
Personal and SME carbon emissions calculators are available 
online (examples include: https ://www.carbo nfoot print.com/
calcu lator.aspx; https ://footp rint.wwf.org.uk/#/; https ://www.
carbo ntrust.com/resou rces/tools/ carbon-footp rint-calcu lator/ 
). Among the key contributors for most people as profession-
als will be travel, consumption of food and goods, IT equip-
ment, hotels, and restaurants, but this is not an exhaustive list 
and we invite other suggestions.
Travel is likely to be a major contributor for many pro-
fessionals and patients. Flying to conferences and meetings 
is likely to be an important component of contributions 
to emissions at the personal professional level. Flying in 
classes other than economy increases emissions signifi-
cantly, for several reasons (eg, see http://blogs.world bank.
org/devel opmen ttalk/ blog-carbon-footp rint-world-bank-
group-staff-air-travel). Various websites, including some 
for academic travel in particular, can help people calculate, 
reduce, or mitigate emissions (eg, www.flyin gless.org and 
https ://thepo intsg uy.com/guide/ a-guide-to-airli ne-carbo 
noffs et-progr ams/). This is a difficult area, as clinical and 
scientific advances and stronger collaborations do emerge 
from face‐to‐face meetings, and teleconferencing still lacks 
both the personal touch and infallible reliability. But perhaps 
not every meeting is essential,65 and to achieve the carbon 
emission reductions necessary to stabilize the climate will 
require us to modify some current practices and find new 
ways to achieve the same outcomes. Targeted distribution of 
mitigation measures (eg, carbon offsetting) for conference 
attendance to those nations most at risk from climate change 
may suit some conference attendees. Higher levels of sus-
tainability at conferences should be considered: hotel usage, 
maintenance of ambient temperatures in conference halls and 
hotels (and personal offices at work), and food and drink pro-
vision at meetings are all areas to be considered. Many or-
ganizations will consider these difficult changes to make for 
meetings that often represent sources of income, but as with 
many aspects of climate change, there is a bigger picture to 
consider. Climate scientists themselves have considered and 
addressed the issue of conference travel (https ://nofly clima 
tesci.org/), even with a model for a “nearly carbon‐neutral 
conference.”74 More flying does not necessarily equate with 
greater academic success.75
Car journeys represent another area in which profession-
als and patients might both contribute, and actions such as 
telehealth initiatives may be possible in some settings and 
jurisdictions, though information technology infrastruc-
ture, privacy, and regulatory issues may present difficulties. 
Professionals can form powerful lobby groups and bring 
these issues to the attention of their organizations. We must 
not be nihilistic. Actions at governmental, institutional, and 
personal levels are required and possible. For example, the 
UK Health Alliance on Climate Change (http://www.ukhea 
lthal liance.org/) advocates “for responses to climate change 
that protect and promote public health.” Online tools are 
available for further ideas and implementation of adaptation 
measures (eg, https ://www.ukcip.org.uk/). Adaptations will 
be necessary and will need to be shaped by outcomes from 
research (ideally shared across diseases), such as improved 
awareness and management of changes in vector ranges or 
medicine manufacture and distribution practice.
Nondomestic contributions to climate change exceed 
those of the residential sector. Companies and institutions 
around the world are beginning to take action: The behav-
ior of employees, including epilepsy professionals, may be 
overlooked in this process, but can be central to the initiation, 
promotion, and success of programs designed to address cli-
mate change. Asking employees to switch their computers off 
at the end of the day, for example, does not mean people will 
do that. Professionals can, however, choose to take the lead. 
Evidence shows that people can be motivated as much by 
“cobenefits” (such as economic and scientific advancement; 
or fostering a more moral and caring community) as they are 
by concern about climate change, whether they are convinced 
about the occurrence of climate change or not.76
Adaptations might include, for example, increased vig-
ilance and preemptive changes in behavior against local 
extreme heat events for people with epilepsy due to heat‐sen-
sitive mutation‐driven genetic epilepsies, informed by local 
(downscaled) modeling of future climate trends, or improved 
short‐term weather forecasting. As precision medicine initia-
tives become more popular, one could envisage inclusion of 
climate change parameters in individualized epilepsy man-
agement schemes.
We summarize some suggestions for actions in Table 2.
8 |  CONCLUSIONS
Clinicians have always considered prevention to be better 
than cure. Minimizing the progress of climate change and 
mitigating emissions now will be cheaper than taking actions 
later when the situation has already gotten worse, although 
there is already a need for some adaptation due to warming 
from historical emissions. The challenge is huge, but it is 
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incumbent upon us to do what we can: This is intrinsic to 
our commitment and duty to patient care and can be seen as 
part of the aim of achieving global equality of health care in 
epilepsy. People have managed huge challenges before—the 
reduction in drink driving rates, the reduced production of 
aerosols, and changes in behavior after the HIV epidemic. 
With climate change, the challenge is bigger, more global, 
and more urgent, but everything counts. Schools, towns, 
local councils, and nations have declared states of “climate 
emergency” (eg, https ://www.bbc.co.uk/news/uk-polit ics-
48126677), with a prominent role played by schoolchildren. 
Should and can a profession take action beyond virtue signal-
ing? And if so, what additional evidence do we need to do 
that? Or in fact can we not afford to wait? We acknowledge 
the links between epilepsy and climate change we discuss are 
speculative, and more research is required. And, of course, 
anything we can do in our personal lives anyway can con-
tribute to help counter one of the biggest challenges facing 
humanity and all life on this planet.
We should perhaps finish with the words of the next gen-
eration, specifically Greta Thunberg (https ://en.wikip edia.
org/wiki/Greta_Thunberg), aged 16, speaking to members 
of the European Parliament and European Union officials 
in Strasbourg on April 16, 2019, after the disastrous fire 
at Notre Dame cathedral: “It is still not too late to act. It 
will take a far‐reaching vision, it will take courage, it will 
take fierce, fierce determination to act now, to lay the foun-
dations where we may not know all the details about how 
to shape the ceiling. In other words, it will take cathedral 
thinking. I ask you to please wake up and make changes 
required possible.”
ACKNOWLEDGEMENTS
We thank G Mirza for technical support. We thank Professors 
Dan Lowenstein and Ingrid Scheffer for permission to in-
clude their travel data in Table 1.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest. We confirm that 
we have read the Journal's position on issues involved in 
T A B L E  2  Actions to consider regarding epilepsy and climate change
Type of action Example
Research
Increase information available on impact 
on climate change on epilepsy and vice 
versa
Apply for research funding; join initiatives addressing these issues
Collect data from people with epilepsy, 
own clinical practice
Establish contact with local and national patient and carer support organizations; gather data 
systematically
Evaluate potential local changes in climate Establish links with local climate scientists, consider local and regional factors (eg, urban vs 
rural)
Report on observations Changing patterns of seizures and comorbidities reported by people with epilepsy; use of social 
media and big data methods
Gather data on mechanistic and personal-
ized medicine domains
Included temperature and humidity parameters in experimental models; quantification of stress 
and consequences in clinical trials; stability of medications
Steps available now
Self‐education and information Join local, national, international initiatives for individuals and professionals; calculate own 
carbon emissions at personal and professional levels
Develop practice approaches that are more 
sustainable
Consider changes with cobenefits to raise chances of engagement and success
Take specific measures Consider travel options; use freely available tools; explore and engage with local health service 
sustainability efforts; lobby institutions, healthcare organizations, journals and conference 
organizers
For organizations Consider measures that facilitate sustainable behavior—for example, earlier setting up of con-
ferences to enable planning of more sustainable travel options
Support people with epilepsy Provide information and advice—for example, when heatwaves are expected; promote tel-
ehealth where possible
Reduce emissions Switch off devices when not needed; promote sustainable practices—for example, enable col-
leagues to attend meetings remotely, record talks for dissemination
Promote sustainability for the next 
generation
Facilitate remote supervision and mentoring; reduce dependence of academic progress upon 
less sustainable practices
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